RBM17 and hepatocellular carcinoma: After matching with known information, we determined that CDC42 [23, 24], CDK11A [25–27], SAC3D1 [28–30], CCNK [31], and INCENP [32–34] were involved in mitosis and apoptosis progression and might be potential downstream targets by which RBM17 can regulate cell proliferation in the development and progression of HCC.